title: Central retinal vein occlusion after intense exercise: response to intravitreal bevacizumab.
abstract: A 40-year-old male athlete developed a central retinal vein occlusion after intense exercise and secondary dehydration. A comprehensive systemic evaluation was within the normal range. After a series of 11 intravitreal injections of bevacizumab over a 24-month period, spectral-domain optical coherence tomography showed resolution of macular edema with a 55-letter gain in visual acuity.
authors.affiliation: Department of Ophthalmology, Bascom Palmer Eye Institute, Miller School of Medicine, University of Miami, Florida 33136, USA.
authors.forename: David J
authors.initials: DJ
authors.lastname: Jacobs
authors.forename: Faisel
authors.initials: F
authors.lastname: Ahmad
authors.forename: Avinash
authors.initials: A
authors.lastname: Pathengay
authors.forename: Harry W
authors.initials: HW
authors.lastname: Flynn
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D004334:Drug Administration Schedule; D015444:Exercise; D005654:Fundus Oculi; D006801:Humans; D058449:Intravitreal Injections; D008266:Macula Lutea / Q000187:drug effects / Q000473:pathology; D008297:Male; D012170:Retinal Vein Occlusion / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology* / Q000473:pathology / Q000503:physiopathology; D041623:Tomography, Optical Coherence / Q000379:methods; D016896:Treatment Outcome; D014792:Visual Acuity / Q000187:drug effects; D014891:Weight Lifting
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab